| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |